Clinical trial
Safety and Efficacy of Ruxolitinib for COVID-19
NCT04348071 is registered in ClinicalTrials.gov with University of Colorado, Denver as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety and Efficacy of Ruxolitinib for COVID-19
- Lead sponsor
- University of Colorado, Denver
- Phase
- Phase 2/3
- Overall status
- Withdrawn
- Start date
- July 31, 2021
- Completion date
- October 31, 2021
- Enrollment
- 0 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.